Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism.

MLA

Rutanen, J., et al. “Gene Transfer Using the Mature Form of VEGF-D Reduces Neointimal Thickening through Nitric Oxide-Dependent Mechanism.” Gene Therapy, vol. 12, no. 12, June 2005, pp. 980–87. EBSCOhost, https://doi.org/10.1038/sj.gt.3302489.

APA

Rutanen, J., Turunen, A.-M., Teittinen, M., Rissanen, T. T., Heikura, T., Koponen, J. K., Gruchala, M., Inkala, M., Jauhiainen, S., Hiltunen, M. O., Turunen, M. P., Stacker, S. A., Achen, M. G., & Ylä-Herttuala, S. (2005). Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism. Gene Therapy, 12(12), 980–987. https://doi.org/10.1038/sj.gt.3302489

Chicago

Rutanen, J, A-M Turunen, M Teittinen, T T Rissanen, T Heikura, J K Koponen, M Gruchala, et al. 2005. “Gene Transfer Using the Mature Form of VEGF-D Reduces Neointimal Thickening through Nitric Oxide-Dependent Mechanism.” Gene Therapy 12 (12): 980–87. doi:10.1038/sj.gt.3302489.